Patent · US Active

Physiologically balanced injectable formulations of fosnetupitant

US10624911B2 · kind B2 · utility

1Cited by

0References

21Claims

0Family size

Assignee

Helsinn Healthcare SA · CH

Inventors

Alessio Venturini · Varese, IT
Roberta Cannella · Varese, IT

Key dates

Filing date	Jun 2, 2017
Grant date	Apr 21, 2020
Priority date	—
Expiry date	Jun 2, 2037

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P1/08
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Injectable dosages and formulations of fosnetupitant and pharmaceutically acceptable salts thereof are provided that are efficacious, chemically stable and physiologically balanced for safety and efficacy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.